Functional genomic screen for modulators of ciliogenesis and cilium length.
Primary cilia are evolutionarily conserved cellular organelles that organize diverse signalling pathways. Defects in the formation or function of primary cilia are associated with a spectrum of human diseases and developmental abnormalities. Genetic screens in model organisms have discovered core machineries of cilium assembly and maintenance. However, regulatory molecules that coordinate the biogenesis of primary cilia with other cellular processes, including cytoskeletal organization, vesicle trafficking and cell-cell adhesion, remain to be identified. Here we report the results of a functional genomic screen using RNA interference (RNAi) to identify human genes involved in ciliogenesis control. The screen identified 36 positive and 13 negative ciliogenesis modulators, which include molecules involved in actin dynamics and vesicle trafficking. Further investigation demonstrated that blocking actin assembly facilitates ciliogenesis by stabilizing the pericentrosomal preciliary compartment (PPC), a previously uncharacterized compact vesiculotubular structure storing transmembrane proteins destined for cilia during the early phase of ciliogenesis. The PPC was labelled by recycling endosome markers. Moreover, knockdown of modulators that are involved in the endocytic recycling pathway affected the formation of the PPC as well as ciliogenesis. Our results uncover a critical regulatory step that couples actin dynamics and endocytic recycling with ciliogenesis, and also provides potential target molecules for future study.
Kim
Joon
J
Department of Neurosciences, Institute for Genomic Medicine, Howard Hughes Medical Institute, University of California San Diego, La Jolla, California 92093, USA.
Lee
Ji Eun
JE
Heynen-Genel
Susanne
S
Suyama
Eigo
E
Ono
Keiichiro
K
Lee
Kiyoung
K
Ideker
Trey
T
Aza-Blanc
Pedro
P
Gleeson
Joseph G
JG
D000199:Actins / Q000378:metabolism; D002460:Cell Line; D002923:Cilia / Q000187:drug effects / Q000235:genetics* / Q000473:pathology / Q000502:physiology*; D015638:Cytochalasin D / Q000494:pharmacology; D004705:Endocytosis; D006801:Humans; D034622:RNA Interference; D025521:Tumor Suppressor Proteins / Q000235:genetics / Q000378:metabolism
D000199:Actins; C098623:IFT88 protein, human; D025521:Tumor Suppressor Proteins; D015638:Cytochalasin D
Mol Biol Cell. 2008 Oct;19(10):4224-37
18685082
Trends Genet. 2006 Sep;22(9):491-500
16860433
Science. 2002 Mar 8;295(5561):1904-6
11884758
J Anat. 1971 Jul;109(Pt 2):277-92
5105129
Nat Genet. 2009 Sep;41(9):1032-6
19668216
Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6308-13
18434552
Cell. 2009 Apr 3;137(1):32-45
19345185
Traffic. 2003 Apr;4(4):214-21
12694560
Nat Rev Mol Cell Biol. 2007 Nov;8(11):880-93
17955020
J Cell Biol. 1962 Nov;15:363-77
13978319
Annu Rev Cell Dev Biol. 2007;23:345-73
17506691
Cell. 2007 Jun 15;129(6):1201-13
17574030
Nat Rev Mol Cell Biol. 2002 Nov;3(11):813-25
12415299
Cell Mol Life Sci. 2006 Jan;63(1):25-35
16314921
Curr Opin Cell Biol. 2000 Feb;12(1):97-103
10679358
J Biol Chem. 2000 Mar 17;275(11):7492-6
10713052
Nat Genet. 2006 Sep;38(9):961-2
16940995
Am J Physiol Renal Physiol. 2002 Mar;282(3):F541-52
11832437
Curr Top Dev Biol. 2008;85:261-301
19147009
Cell Mol Life Sci. 2004 Oct;61(19-20):2614-23
15526166
J Cell Biol. 2007 Jul 30;178(3):363-9
17646400
Nat Cell Biol. 2009 Nov;11(11):1332-9
19855387
Agents Actions. 1993;39 Spec No:C39-42
8273580
Nature. 2005 Oct 13;437(7061):1018-21
16136078
Nat Rev Mol Cell Biol. 2004 Feb;5(2):121-32
15040445